amifostine anhydrous has been researched along with Genetic Diseases in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This list comprises genetic diseases (xeroderma pigmentosum, glucose-6-phosphate dehydrogenase deficiency), autoimmune disorders (vitiligo, scleroderma, thyroiditis, perforating collagenosis), metabolic diseases (diabetes mellitus), cardiovascular diseases, neuro/psychiatric diseases and other medical conditions (hypoglycemia, hepatic cirrhosis, alcoholism)." | 2.43 | Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases. ( Koukourakis, MI; Maltezos, E, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koukourakis, MI | 1 |
| Maltezos, E | 1 |
1 review available for amifostine anhydrous and Genetic Diseases
| Article | Year |
|---|---|
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.
Topics: Amifostine; Autoimmune Diseases; Combined Modality Therapy; Comorbidity; Genetic Diseases, Inborn; H | 2006 |